Category: CARDIOLOGY

New evidence for benefits of transcatheter edge-to-edge repair in secondary tricuspid regurgitation

Tri.fr trial PICOT scheme Designed by Alex Sticchi. Source: PCRonline Tricuspid transcatheter edge-to-edge repair (T-TEER) significantly reduced the severity of secondary tricuspid regurgitation and improved quality of life after one

Rare genetic variants linked to bicuspid aortic valve disease in young adults identified

Credit: CC0 Public Domain Genetic variants linked to a rare form of bicuspid aortic valve disease that affects young adults and can lead to dangerous and potentially life-threatening aortic complications

Trial investigates use of invasive strategy to treat older patients after non-ST-elevation myocardial infarction

Credit: Lynn Greyling/public domain An invasive strategy vs. optimal medical therapy alone after a non-ST-elevation myocardial infarction (NSTEMI) in older adults did not affect the combined risk of cardiovascular death

Beta-blockers do not affect patients’ quality of life, study finds

Credit: CC0 Public Domain Long-term use of beta-blockers in patients with myocardial infarction and preserved heart function does not significantly change quality of life or well-being compared to no beta-blockers.

Large trial suggests AI for heart scans may benefit decision making for less-experienced clinicians

Credit: MART PRODUCTION from Pexels A large randomized trial showed no significant differences to demonstrate that using artificial intelligence (AI) to aid clinical decision-making in assessing heart ultrasounds is as

Using AI to support heart attack diagnosis in emergency department does not improve patient outcomes, research finds

Credit: Unsplash/CC0 Public Domain Using artificial intelligence (AI) to aid clinical decision making in identifying and managing myocardial infarction (MI; heart attack) in patients presenting to the emergency department (ED)

Anticoagulation may have greater benefit in patients with vascular disease

Graphical Abstract. Credit: European Heart Journal (2024). DOI: 10.1093/eurheartj/ehae596 A combined subgroup analysis of the similar trials NOAH—AFNET 6 and ARTESiA has revealed that patients with device-detected atrial fibrillation and

Trial finds drug-coated balloon angioplasty less effective than second generation drug-eluting stents

Credit: Pixabay/CC0 Public Domain Novel drug-coated balloons (DCB) did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise finding of the

Researchers map carbon footprint of cardiac patients, from hospital admission to discharge

An extract of the concordance used to connect the expenditure information provided by the SLHD and the financial information contained within the input–output table. A value of 1 represents a

Biomarkers may predict future sinus rhythm in patients with atrial fibrillation

by Kompetenznetz Vorhofflimmern e.V. (AFNET) Graphical Abstract. Credit: European Heart Journal (2024). DOI: 10.1093/eurheartj/ehae611 Low concentrations of three selected biomarkers in the blood of patients with atrial fibrillation identify patients